Case-based review: atypical teratoid/rhabdoid tumor

Area of Science:

• Pediatric Oncology
• Neuro-oncology
• Cancer Genomics

Background:

• Atypical teratoid/rhabdoid tumor (AT/RT) is a rare, aggressive embryonal tumor of the central nervous system (CNS) primarily affecting children under 3.
• Histologically, AT/RTs exhibit a rhabdoid component alongside primitive neuroectodermal, mesenchymal, and epithelial features.
• Rapid growth and early presentation often lead to critical complications like brain compression and intracranial hypertension.

Purpose of the Study:

• To review the current understanding of AT/RT, highlighting challenges in treatment over the past three decades.
• To emphasize recent advancements in molecular pathogenesis and their implications for novel therapeutic strategies.
• To provide an overview of ongoing clinical trials for molecularly targeted therapies in AT/RT.

Main Methods:

• Review of recent large-scale, multicenter interdisciplinary studies on AT/RT.
• Analysis of molecular data to understand tumor pathogenesis.
• Summary of current treatment modalities and ongoing clinical trials.

Main Results:

• Despite aggressive treatment (surgery, chemotherapy, radiotherapy), progress has been limited by data scarcity and tumor aggressiveness.
• Recent molecular studies have significantly improved the understanding of AT/RT pathogenesis.
• Multiple clinical trials are actively investigating molecularly targeted therapies.

Conclusions:

• AT/RT remains a challenging pediatric CNS cancer with a poor prognosis.
• Advances in molecular understanding are paving the way for more effective, targeted treatments.
• Ongoing clinical trials offer new hope for improved outcomes in children with AT/RT.